Search

everythinglearnresearchcommunity

for

Search:↓

A substance called sodium zinc dihydrolipoylhistidinate can significantly reduce hair loss caused by chemotherapy in rats.

Prevent persistent hair loss after chemotherapy with scalp cooling and early minoxidil use.

Selective chemical epilation effectively treats tinea capitis without harmful side effects.

ONO-3403 effectively reduces mouse skin tumor growth without side effects.

DHL-HisZnNa may help reduce hair loss from chemotherapy, but more research is needed.

Increased EGFR gene variations may predict chemotherapy outcomes in small cell lung cancer patients.

The combination of high-dose toremifene and capecitabine was effective for advanced recurrent breast cancer.

Selaginella doederleinii extract shows potential for cervical cancer treatment but needs more research.

A rare genetic variant linked to skin cysts was found in blood DNA, suggesting its role in cyst formation.

The conclusion is that effective cancer treatment often requires a combination of therapies, but must be carefully managed due to serious side effects and the risk of immunosuppression.

Targeted radionuclide therapy shows promise for improving head and neck cancer treatment but needs more research.

Activated protein C helps protect mice from long-term radiation damage.

Immunotherapy with pembrolizumab significantly reduced cancer in a young woman with adrenocortical carcinoma.

Low-intensity ultrasound may protect hair follicles from damage caused by a common chemotherapy drug.

Some chemotherapy can cause permanent hair loss.

Talazoparib is more effective than standard chemotherapy for advanced breast cancer with BRCA mutations.

Spermidine may improve skin health and hair growth by enhancing cell function.

The calcineurin/NFAT pathway plays a significant role in the development and growth of a type of skin cancer called cutaneous squamous cell carcinoma.

CENPV, a new partner of CYLD, helps regulate ciliary acetylated tubulin and is overexpressed in certain skin tumors.

The drug showed promise in treating renal cell carcinoma with manageable side effects.

INTASYL is a promising, adaptable RNAi technology for treating skin cancers.

Doctors should collaborate with the patient's primary care physician to decide if it's safe to stop taking Plavix before hair restoration surgery, considering the risk and benefit.

ICI therapy increases the risk of gastrointestinal and endocrine issues in psoriasis patients.

A substance called Compound 2g can strongly block STS (a hormone-related enzyme) without affecting estrogen levels, making it potentially good for treating breast cancer.

The topical inhibitor CUR61414 was not effective in treating basal cell carcinoma in human trials.

The combination of mitoxantrone, etoposide, and prednisolone is effective for treating relapsed lymphoma with manageable side effects.

Polyamines help repair DNA breaks and may influence cancer development.

Chemotherapy can cause permanent hair loss.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

CHOP chemotherapy causes many side effects but is generally well tolerated.